JAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)

Yang, C-H.; Dols, M. Cobo; Skuladottir, H.; Park, K.; Sullivan, R.; Veatch, A. L.; Pavlakis, N.; Dreosti, L. M.; Morgillo, F.; Schlichting, M.; Teofilovici, F.; Chand, V.; Westeel, V.; Ozguroglu, M.; Kim, T. M.; Reck, M.; Thomas, M.; Font, E. F.; Barlesi, F.; Postmus, P. E.

dc.contributor.author	Yang, C-H.
dc.contributor.author	Dols, M. Cobo
dc.contributor.author	Skuladottir, H.
dc.contributor.author	Park, K.
dc.contributor.author	Sullivan, R.
dc.contributor.author	Veatch, A. L.
dc.contributor.author	Pavlakis, N.
dc.contributor.author	Dreosti, L. M.
dc.contributor.author	Morgillo, F.
dc.contributor.author	Schlichting, M.
dc.contributor.author	Teofilovici, F.
dc.contributor.author	Chand, V.
dc.contributor.author	Westeel, V.
dc.contributor.author	Ozguroglu, M.
dc.contributor.author	Kim, T. M.
dc.contributor.author	Reck, M.
dc.contributor.author	Thomas, M.
dc.contributor.author	Font, E. F.
dc.contributor.author	Barlesi, F.
dc.contributor.author	Postmus, P. E.
dc.date.accessioned	2021-03-03T17:27:16Z
dc.date.available	2021-03-03T17:27:16Z
dc.identifier.citation	Reck M., Yang C., Postmus P. E. , Barlesi F., Font E. F. , Thomas M., Kim T. M. , Dols M. C. , Skuladottir H., Park K., et al., "JAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)", 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28
dc.identifier.other	vv_1032021
dc.identifier.other	av_49d3d884-035f-483e-91f9-95586f47b1d6
dc.identifier.uri	http://hdl.handle.net/20.500.12627/53061
dc.language.iso	eng
dc.subject	İç Hastalıkları
dc.subject	Dahili Tıp Bilimleri
dc.subject	Sağlık Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.subject	Onkoloji
dc.title	JAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)
dc.type	Bildiri
dc.contributor.department	Grosshansdorf Hospital , ,
dc.identifier.volume	28
dc.contributor.firstauthorID	152207

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster